StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.15−0.03 (-2.54%)

Close on Nov 17, 2026Market cap $83.14MP/E –Yield –

InflaRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

InflaRx's price to sales ratio was 276.6× on Feb 27, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 2026276.6×−29.3
2025Dec 31, 2025305.9×–

More InflaRx figures

See a number that looks wrong?